Yanan Bikan Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
- The company's stock will be delisted on the trading day following the end of the delisting transition period.
- The start date of the delisting transition period is June 19, 2023, with the expected last trading date being July 11, 2023.
- The trading period for the delisting transition is fifteen trading days. Investors are advised to make prudent decisions and be aware of investment risks.
- During the delisting transition period, the company will not plan or implement any major asset restructuring matters.
- Investors, securities companies, and other market participants should settle stock pledge repurchase, agreed repurchase, margin financing, transfer of financing, and Shenzhen Stock Connect businesses in a timely manner before the stock is delisted.
- For judicial freeze businesses that will expire after the stock is delisted and before the completion of the initial registration in the delisting sector, it is recommended that the competent authorities handle the renewal procedures in advance through the original enforcement channels before the stock is delisted.